Mitsubishi Chemical acquires TPU business of US Enterprises

Recently, Mitsubishi Chemical announced that it acquired the thermoplastic polyurethane (TPU) elastomer business of advansource biomaterials (ASB) in Massachusetts The acquisition is planned to be completed in January 2020 ASB has a high-end TPU business in the United States, and its products are mainly used for medical equipment, such as cardiovascular catheters The good biocompatibility, antibacterial and flexibility of TPU make it indispensable for cardiovascular catheters and other device applications for body insertion Mitsubishi Chemical said that its high-performance polymer business has been expanded through M & A and other measures, and now it can provide various types of elastomer solutions Through this acquisition, Mitsubishi Chemical will obtain material certification and sales channels in the US medical device market, further expand its product portfolio to TPU technology, and accelerate the market development of existing businesses.